Legislators in Germany are focused on creating a pilot program for the commercial sale of marijuana. This comes after the country legalized the possession and cultivation of marijuana for personal use last week. Under the new law, social clubs where individuals could join and acquire cannabis are set for launch in July.
In its statement, the Federal Ministry of Health stated that preparation work on the next pillar of the marijuana laws was underway with relevant departments. He also noted, however, that no specifics cold be shared at the time.
Karl Lauterbach, the health minister who has championed for marijuana legalization, stated in the Bundestag last year that government officials were assessing the commercial sales measure. Now that the law is in effect, pressure to hasten commercial sales has increased.
Free Democratic Party’s Kristine Lütke stated that establishing a commercial program for the drug was a need, noting that she looked forward to Lauterbach presenting a draft that would address this need. Lütke then acknowledged that follow-up sales measures would face higher resistance in the Bundesrat, which represents individual states.
It is expected that the measure will be exposed to potential pushbacks and criticism, primarily because dispensaries would gain visibility. In the past, the Bundesrat tried preventing the legalization measure from being enacted but failed. Despite this, members of the legislative body entered an agreement with other ministers as well as Lauterbach, refusing to refer the marijuana measure to a mediation committee because this would’ve delayed implementation.
The Green Party’s Kirsten Kappert-Gonther stated that she agreed that commercial sales were important in creating alternatives to the black market and minimizing health risk for occasional users.
The measure to legalize commercial sales will be unveiled after submission to the European Commission for review. Germany’s government wanted to obtain signoff from the European Union after approving the initial framework for a legalization bill to ensure that enacting the bill wouldn’t violate any global obligations.
In 2022, officials in government flagged off hearings focused on informing the bill to eliminate marijuana prohibition in Germany. That same year, a group of legislators from Germany as well as Narcotics Drugs Commissioner Burkhard Blienert visited the United States and toured marijuana businesses in California to inform their nation’s approach to legalization. This came after a global survey in 2022 determined that most support for marijuana’s legalization was from European nations such as Germany.
The next year, officials from different nations including the U.S., met in Germany to discuss global cannabis policy issues. As the recreational market for marijuana takes off and expands, major players based in other regions of the world, such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), could take an interest in any opportunities that arise to enter the lucrative German market.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
